These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally. The Company operates through three segments: Enzo Life Sciences, Enzo Clinical Labs and Enzo Therapeutics. Enzo Life Sciences segment manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers around the world. Enzo Clinical Labs segment provides diagnostic services to the healthcare community. Enzo Therapeutics segment conducts research and development activities for therapeutic drug candidates.

Employee Rating

3.5More
TypePublic
HQNew York, US
Founded1976
Size (employees)460 (est)+7%
Websiteenzo.com
Enzo Biochem was founded in 1976 and is headquartered in New York, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Enzo Biochem Office Locations

Enzo Biochem has an office in New York
New York, US (HQ)
527 Madison Ave
Show all (1)
Report incorrect company information

Enzo Biochem Financials and Metrics

Enzo Biochem Revenue

Enzo Biochem's revenue was reported to be $104.71 m in FY, 2018
USD

Revenue (Q1, 2019)

21.3m

Gross profit (Q1, 2019)

7.0m

Gross profit margin (Q1, 2019), %

33%

Net income (Q1, 2019)

(6.0m)

EBIT (Q1, 2019)

(6.0m)

Market capitalization (14-Dec-2018)

136.4m

Closing stock price (14-Dec-2018)

2.9

Cash (31-Oct-2018)

52.8m
Enzo Biochem's current market capitalization is $136.4 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

93.7m95.9m97.6m102.8m107.8m104.7m

Revenue growth, %

2%2%5%

Cost of goods sold

46.0m

Gross profit

58.7m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

24.1m22.9m24.0m24.8m23.1m24.0m25.2m24.6m26.4m26.3m26.3m27.1m27.7m27.0m25.6m21.3m

Cost of goods sold

11.0m14.2m

Gross profit

14.6m7.0m

Gross profit Margin, %

57%33%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

9.0m17.5m18.1m67.8m64.2m60.0m

Accounts Receivable

12.3m12.5m6.7m6.7m

Inventories

8.8m8.7m7.4m7.0m7.0m7.3m

Current Assets

32.6m40.7m46.5m91.4m89.1m83.2m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

7.4m7.6m14.8m16.6m15.3m14.4m30.6m37.0m32.4m67.2m62.4m62.6m66.8m64.5m62.6m52.8m

Accounts Receivable

6.7m6.7m

Inventories

9.1m9.2m9.0m8.5m8.3m8.0m7.6m7.4m7.0m7.2m7.1m7.2m7.2m7.5m7.3m7.6m

Current Assets

32.4m30.6m38.2m39.7m37.0m36.1m52.8m59.2m55.2m90.4m86.9m87.5m91.0m89.5m86.4m75.5m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(18.2m)(10.0m)(2.3m)45.3m(2.5m)(10.3m)

Inventories

60.0k159.0k1.2m466.0k92.0k(413.0k)

Cash From Operating Activities

(10.0m)(1.7m)(3.7m)53.1m(205.0k)(2.7m)

Cash From Investing Activities

(971.0k)(833.0k)(1.8m)(1.5m)(1.7m)(1.9m)
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Net Income

(2.8m)(6.4m)(6.8m)(3.7m)(7.8m)(10.7m)4.4m11.3m9.2m(1.5m)(2.5m)(2.6m)(640.0k)(1.5m)(4.6m)(6.0m)

Inventories

(252.0k)(381.0k)(144.0k)107.0k306.0k597.0k(210.0k)(20.0k)447.0k(298.0k)(238.0k)(213.0k)(198.0k)(430.0k)(257.0k)(309.0k)

Cash From Operating Activities

(3.3m)(4.7m)(2.7m)(2.8m)(6.5m)(8.2m)13.2m20.1m17.0m(333.0k)(2.8m)(1.9m)2.6m835.0k(475.0k)(6.2m)

Cash From Investing Activities

(314.0k)(472.0k)(524.0k)(259.0k)(653.0k)(1.2m)(490.0k)(941.0k)(1.4m)(514.0k)(687.0k)(1.4m)(461.0k)(1.1m)(1.7m)(1.0m)
USDY, 2018

Financial Leverage

1.2 x
Show all financial metrics

Enzo Biochem Operating Metrics

FY, 2016

Facilities

2

Patents Issued

314

Patents Pending

146
Show all operating metrics

Enzo Biochem Revenue Breakdown

Embed Graph

Enzo Biochem revenue breakdown by business segment: 69.0% from Clinical Labs and 31.0% from Life Sciences

Report incorrect company information

Enzo Biochem News and Updates

Report incorrect company information

Enzo Biochem Company Life and Culture

Report incorrect company information

Enzo Biochem Frequently Asked Questions

  • When was Enzo Biochem founded?

    Enzo Biochem was founded in 1976.

  • How many employees does Enzo Biochem have?

    Enzo Biochem has 460 employees.

  • What is Enzo Biochem revenue?

    Latest Enzo Biochem annual revenue is $104.7 m.

  • What is Enzo Biochem revenue per employee?

    Latest Enzo Biochem revenue per employee is $227.6 k.

  • Who are Enzo Biochem competitors?

    Competitors of Enzo Biochem include Biotage , goBalto and Creative Medical Technology Holdings.

  • Where is Enzo Biochem headquarters?

    Enzo Biochem headquarters is located at 527 Madison Ave, New York.

  • Where are Enzo Biochem offices?

    Enzo Biochem has an office in New York.

  • How many offices does Enzo Biochem have?

    Enzo Biochem has 1 office.